Linked Life Data

10229326

Source:http://linkedlifedata.com/resource/pubmed/id/10229326

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10229326rdf:typepubmed:Citationlld:pubmed
pubmed-article:10229326lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:10229326lifeskim:mentionsumls-concept:C1517806lld:lifeskim
pubmed-article:10229326lifeskim:mentionsumls-concept:C0596902lld:lifeskim
pubmed-article:10229326lifeskim:mentionsumls-concept:C0017725lld:lifeskim
pubmed-article:10229326lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:10229326lifeskim:mentionsumls-concept:C0205217lld:lifeskim
pubmed-article:10229326lifeskim:mentionsumls-concept:C1510827lld:lifeskim
pubmed-article:10229326pubmed:issue4lld:pubmed
pubmed-article:10229326pubmed:dateCreated1999-5-25lld:pubmed
pubmed-article:10229326pubmed:abstractTextTo elucidate the role of N-glycosylation in the functional activity of the universal glucose transporter, Glut-1, we investigated effects of the N-glycosylation inhibitor, tunicamycin, on glucose transport by human leukemic cell lines K562, U937 and HL60. Treatment with tunicamycin produced a 40-50% inhibition of 2-deoxyglucose uptake and this was associated with a 2-2.5-fold decrease in transporter affinity for glucose (Km) without a change in Vmax. Leukemic K562, U937 and HL60 cells expressed Glut-1 transporter protein. With K562 cells Glut-1 appeared as a broad band of 50-60 kDa, whereas with U937 and HL60 cells a diffuse band was observed at approximately 55 kDa. Treatment of K562 cells with tunicamycin for 18 h, resulted in extensive loss of the 50-60 kDa glycoprotein, appearance of a 30-40 kDa band and increased staining of a 45 kDa band. With U937 cells, tunicamycin treatment resulted in the appearance of a 30-40 kDa band and increased staining of a 45 kDa band. With HL60 cells loss of the 55 kDa Glut-1 band was observed and a band of 45 kDa appeared. Tunicamycin-treatment resulted in 75-90% inhibition in [3H]mannose incorporation but only 20-25% inhibition in [3H]thymidine and [3H]leucine incorporation. In contrast, tunicamycin had little effect on the viability and MTT responses of the cells used. These results suggest that in leukemic cells N-glycosylation of Glut-1 plays an important role in maintaining its structure and functional integration.lld:pubmed
pubmed-article:10229326pubmed:languageenglld:pubmed
pubmed-article:10229326pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10229326pubmed:citationSubsetIMlld:pubmed
pubmed-article:10229326pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10229326pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10229326pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10229326pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10229326pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10229326pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10229326pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10229326pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10229326pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10229326pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10229326pubmed:statusMEDLINElld:pubmed
pubmed-article:10229326pubmed:monthAprlld:pubmed
pubmed-article:10229326pubmed:issn0145-2126lld:pubmed
pubmed-article:10229326pubmed:authorpubmed-author:AhmedNNlld:pubmed
pubmed-article:10229326pubmed:authorpubmed-author:BerridgeM VMVlld:pubmed
pubmed-article:10229326pubmed:issnTypePrintlld:pubmed
pubmed-article:10229326pubmed:volume23lld:pubmed
pubmed-article:10229326pubmed:ownerNLMlld:pubmed
pubmed-article:10229326pubmed:authorsCompleteYlld:pubmed
pubmed-article:10229326pubmed:pagination395-401lld:pubmed
pubmed-article:10229326pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10229326pubmed:meshHeadingpubmed-meshheading:10229326...lld:pubmed
pubmed-article:10229326pubmed:meshHeadingpubmed-meshheading:10229326...lld:pubmed
pubmed-article:10229326pubmed:meshHeadingpubmed-meshheading:10229326...lld:pubmed
pubmed-article:10229326pubmed:meshHeadingpubmed-meshheading:10229326...lld:pubmed
pubmed-article:10229326pubmed:meshHeadingpubmed-meshheading:10229326...lld:pubmed
pubmed-article:10229326pubmed:meshHeadingpubmed-meshheading:10229326...lld:pubmed
pubmed-article:10229326pubmed:meshHeadingpubmed-meshheading:10229326...lld:pubmed
pubmed-article:10229326pubmed:meshHeadingpubmed-meshheading:10229326...lld:pubmed
pubmed-article:10229326pubmed:meshHeadingpubmed-meshheading:10229326...lld:pubmed
pubmed-article:10229326pubmed:meshHeadingpubmed-meshheading:10229326...lld:pubmed
pubmed-article:10229326pubmed:meshHeadingpubmed-meshheading:10229326...lld:pubmed
pubmed-article:10229326pubmed:meshHeadingpubmed-meshheading:10229326...lld:pubmed
pubmed-article:10229326pubmed:meshHeadingpubmed-meshheading:10229326...lld:pubmed
pubmed-article:10229326pubmed:meshHeadingpubmed-meshheading:10229326...lld:pubmed
pubmed-article:10229326pubmed:meshHeadingpubmed-meshheading:10229326...lld:pubmed
pubmed-article:10229326pubmed:year1999lld:pubmed
pubmed-article:10229326pubmed:articleTitleN-glycosylation of glucose transporter-1 (Glut-1) is associated with increased transporter affinity for glucose in human leukemic cells.lld:pubmed
pubmed-article:10229326pubmed:affiliationMalaghan Institute of Medical Research, Wellington School of Medicine, Wellington South, New Zealand. nahmed@mail.newcastle.edu.aulld:pubmed
pubmed-article:10229326pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10229326pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10229326lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10229326lld:pubmed